Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus

Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain

(2017) I Aguilar et al.   Eurosurveillance

Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12

(2017) J Castilla et al.   Eurosurveillance

Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season

(2016) Jesús Castilla et al.   Eurosurveillance

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States

(2016) Manjusha Gaglani et al.   JOURNAL OF INFECTIOUS DISEASES

Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains

(2016) Joshua G. Petrie et al.   JOURNAL OF INFECTIOUS DISEASES

Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons

(2016) Jesús Castilla et al.   VACCINE

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11

(2016) Mark G. Thompson et al.   VACCINE

Immune history profoundly affects broadly protective B cell responses to influenza

(2015) Sarah F. Andrews et al.   Science Translational Medicine

Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus

(2015) Iván Martínez-Baz et al.   Human Vaccines & Immunotherapeutics

Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons

(2014) Huong Q. McLean et al.   CLINICAL INFECTIOUS DISEASES

Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011–2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine

(2014) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season

(2014) S. L. Linderman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study

(2013) Iván Martínez-Baz et al.   BMC PUBLIC HEALTH

Stratified Estimates of Influenza Vaccine Effectiveness by Prior Vaccination: Caution Required

(2013) S. G. Sullivan et al.   CLINICAL INFECTIOUS DISEASES

Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

(2013) Suzanne E. Ohmit et al.   CLINICAL INFECTIOUS DISEASES

Influenza Vaccine Effectiveness in the Community and the Household

(2013) S. E. Ohmit et al.   CLINICAL INFECTIOUS DISEASES

A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season

(2012) Danuta M. Skowronski et al.   CLINICAL INFECTIOUS DISEASES

Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom

(2012) R. G. PEBODY et al.   EPIDEMIOLOGY AND INFECTION

Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season

(2012) H. ENGLUND et al.   EPIDEMIOLOGY AND INFECTION

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

(2012) G.-M. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effectiveness of the 2010–11 seasonal trivalent influenza vaccine in Spain: cycEVA study

(2012) S. Jiménez-Jorge et al.   VACCINE

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009–2010: Cohort and case-control study

(2011) Jesús Castilla et al.   VACCINE

Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks

(2010) Marta Valenciano et al.   VACCINE

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

(2009) Kathy Hancock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines

(2009) W. Ndifon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database

(2009) Michele Pellegrini et al.   VACCINE

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

(2008) Jens Wrammert et al.   NATURE